Preparation, characterization, and antitumor activity of new cisplatin analogs with homopiperazines: Crystal structure of [Pt(II)(1- methylhomopiperazine)(methylmalonato)]·2H2O

Journal of Inorganic Biochemistry

Volumn 77, Issue 3-4, 1999, Pages 231-238

  Ali, Mohammad S ^a   Whitmire, Kenton H ^b   Toyomasu, Taisuke ^a   Siddik, Zahid H ^a   Khokhar, Abdul R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b RICE UNIVERSITY   (United States)

Author keywords

Antitumor agents; Carboxylates; Crystal structure; Homopiperazine; Platinum; Synthesis

Indexed keywords

CISPLATIN; PIPERAZINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CRYSTAL STRUCTURE; GEOMETRY; HYDROGEN BOND; LIGAND BINDING; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTINEOPLASTIC AGENTS; CRYSTALLOGRAPHY, X-RAY; HUMANS; MODELS, MOLECULAR; ORGANOPLATINUM COMPOUNDS; TUMOR CELLS, CULTURED;

EID: 0033394537     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(99)00208-1     Document Type: Article

References (66)

1. Loehrer P.J., Einhorn L. Ann. Intern. Med. 100:1984;704.
2. E. Reed, K.W. Kohn, in: B.A. Chabner, J. Collins (Eds.), Cancer Chemotherapy Principles and Practice, J.B. Lippincott, Philadelphia, PA, 1990, p. 465.
3. W.B. Pratt, R.W. Ruddon, W.D. Ensminger, J. Maybaum, in: The Anticancer Drugs, Oxford University Press, New York, 1994, p. 133.
4. Krakoff I.H. Cancer Treat. Rep. 63:1979;1523.
5. Vermorken J.B., Pinedos H.M. Neth. J. Med. 25:1982;270.
6. Vonhoff D.D., Schilsky R., Reichart C.M. Cancer Treat. Rep. 63:1979;1527.
7. I.H. Krakoff, in: M. Nicolini (Ed.), Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy: Clinical Application of Platinum Complexes, Martinus Nijhoff, Boston, MA, 1988, p. 351.
8. Loehrer P.J., Williams Sr S.D., Einhorn L.H. J. Natl. Cancer Inst. 80:1988;1373.
9. Keder A., Cohen M.E., Freeman A.I. Cancer Treat. Rep. 62:1978;819.
10. M.J. Cleare, P.C. Hydes, D.R. Hepburn, B.W. Melerbi, in: A.W. Prestayko, S.T. Crooke, K. Carter (Eds.), Cisplatin, Current Status and New Development, Academic Press, New York, 1980, p. 149.
11. Connors T.A., Cleare M.J., Harrap K.R. Cancer Treat. Rep. 63:1979;1499.
12. K.R. Harrap, in: F.M. Muggia (Ed.), Cancer Chemotherapy, vol. 1, Martinus Nijhoff, Boston, MA, 1983, p. 171.
13. P.C. Hydes, in: M.P. Hacker, E.B. Douple, I.H. Krakoff (Eds.), Platinum Coordination Complexes in Cancer Chemotherapy, Martinus Nijhoff, Boston, MA, 1984, p. 216.
14. Calvert A.H., Harland S.J., Newell D.R., Siddik Z.H., Harrap K.R. Cancer Treat. Rev. (suppl. A). 12:1985;51.
15. Booth B.W., Weiss R.B., Korzun A.H., Wood W.C., Carey R.W., Panasci L.P. Cancer Treat. Rep. 69:1985;919.
16. (a) R. Perez-Soler, A.R. Khokhar, M.P. Hacker, G. Lopez-Berestein, Cancer Res. 46 (1986) 6269.
17. (b) A.R. Khokhar, S. Al-Baker, I.H. Krakoff, R. Perez-Soler, Cancer Chemother. Pharmacol. 23 (1989) 219.
18. (c) A.R. Khokhar, S. Al-Baker, R. Perez-Soler, Anti-Cancer Drugs. 3 (1992) 95.
19. (d) W. Schmidt, S. Chaney, Cancer Res. 53 (1993) 799.
20. (a) A. Eastman, S. Illenye, Cancer Treat. Rep. 68 (1984) 1189.
21. (b) J.H. Burchenal, K. Kalaher, K. Dew, L. Lokys, G. Gale, Biochimie 60 (1978) 961.
22. (c) J.H. Burchenal, K. Kalaher, R. O'Toole, J. Chisholm, Cancer Res. 37 (1977) 3455.
23. Perez-Soler R., Lopez-Berestein G., Luthersztain J., Al-Baker S., Francis K., Macias-Kiger D., Raber M.N., Khokhar A.R. Cancer Res. 50:1990;4254.
24. Extra J.M., Espie M., Calvo F., Ferme C., Mignot L., Marty M. Cancer Chemother. Pharmocol. 25:1990;299.
25. (a) S. Shamsuddin, I. Takahasshi, Z.H. Siddik, A.R. Khokhar, J. Inorg. Biochem. 61 (1996) 291.
26. (b) Q. Xu, A.R. Khokhar, J. Inorg. Biochem. 48 (1992) 217.
27. (c) S. Shamsuddin, J.W. van Hal, J.L. Stark, K.H. Whitmire, A.R. Khokhar, Inorg. Chem. 36 (1997) 5969.
28. (d) A.R. Khokhar, S. Al-Baker, Z.H. Siddik, J. Inorg. Biochem. 54 (1994) 39.
29. (e) A.R. Khokhar, S. Shamsuddin, Q. Xu, Inorg. Chim. Acta 219 (1994) 193.
30. (f) S. Shamsuddin, C.C. Santillan, J.L. Stark, K.H. Whitmire, Z.H.Siddik, A.R. Khokhar, J. Inorg. Biochem. 71 (1998) 29.
31. Christinan M.C., Kohn E., Sarosy G., Link C., Davis P., Adamo D., Weiss R.B., Brewster L., Lombardo F., Reed E. Proc. Am. Soc. Clin. Oncol. (Abstract). 11:1992;117.
32. I. Judson, M. McKeage, J. Hanwell, C. Berry, P. Mistry, F. Raymond, G. Poon, B. Murrer, K. Harrap, in: Platinum and Other Metal Coordination Complexes in Cancer Chemotherapy: The Clinical Development of the Oral Platinum Anticancer Agent JM216, H.M. Press, New York, 1996, p. 83.
33. (a) T.W. Hambley, E.C.H. Ling, B.A. Messerle, Inorg. Chem. 35 (1996) 4663.
34. (b) A.L. Pinto, S.J.Lippard, Biochem. Biophys. Acta 780 (1985) 167.
35. (c) J.L. van der Veer, J.J. Reedijk, J. Chem. Br. 24 (1988) 775.
36. (c) N. Sheibani, M.M. Jennerwein, A. Eastman, Biochemistry 28 (1989) 3120.
37. (a) A. Eastman, Biochemistry 22 (1983) 3927.
38. (b) A.M.J. Fichtinger-Schepman, P.H.M. Lohman, J. Reedijk, Nucleic Acids Res.10 (1982) 5345.
39. (c) A.M.J. Fichtinger-Schepman, J.L. Van Der Veer, J.H.J. Den Hartog, P.H.M. Lohman, J. Reedijk, Biochemistry 24 (1985) 707.
40. (d) A. Eastman, Biochemistry 24 (1985) 5027.
41. (e) A. Eastman, Biochemistry 25 (1986) 3912.
42. (a) J.C. Jones, W. Zhen, E. Reed, R.J. Parker, A. Sancer, V.A. Bohr, J. Biol. Chem. 266 (1991) 7101.
43. (b) W. Zhen, C.J. Link Jr, P.M. O'Connor, E. Reed, R. Parker, S.B. Howell, V.A. Bohr, Mol. Cell Biol. 12 (1992) 3689.
44. (c) Y. Corda, C. Job, M.F. Anin, M. Leng, D. Job, Biochemistry 32 (1993) 8582.
45. (a) N. Sheibani, M.M. Jennerwein, A. Eastman, Biochemistry 28 (1989) 3120.
46. (b) A.L. Pinto, L.J. Naser, J.M. Essigmann, S.J. Lippard, J. Am. Chem. Soc. 108 (1986) 7405.
47. E.C.H. Ling, G.W. Allen, T.W. Hambley, J. Am. Chem. Soc. 116 (1994) 2673.
48. TEXSAN: Single Crystal Analysis Software, Version 5.0, Molecular Structure Corporation, The Woodlands, TX, 1989.
49. The scattering factors are part of the SHELX-93 package and can be found in the International Tables for X-ray Crystallography, Kluwer, vol. C, Dordrecht, 1992, Tables 4.2.6.8 and 6.1.1.4.
50. SHELXTL-PLUS PC, Version 4.2, Siemens Crystallographic Research Systems, Madison, WI, 1990.
51. G.M. Sheldrick, SHELXL-93, Göttingen, Germany, 1993.
52. Siddik Z.H., Mims B., Lozano G., Thai G. Cancer Res. 58:1998;698.
53. Dhara S.C. Ind. J. Chem. 8:1970;193.
54. K. Nakamato, in: Infrared and Raman Spectra of Inorganic and Coordination Compounds, 4th ed., Wiley, New York, 1986, p. 383.
55. (a) A.R. Khokhar, S. Al-Baker, T. Brown, R. Perez-Soler, J. Med. Chem. 34 (1991) 321.
56. (b) S. Al-Baker, R. Perez-Soler, A.R. Khokar, J. Inorg. Biochem. 47 (1992) 99.
57. (c) S. Shamsuddin, M.S. Ali, A.R. Khokhar, J. Coord. Chem., in press
58. (d) S. Al-Baker, R. Perez-Soler, A.R. Khokhar, J. Coord. Chem. 29 (1993) 1.
59. Al-Baker S., Dabrowiak J.C. Inorg. Chem. 26:1987;613.
60. Brandon R.J., Dabrowiak J.C. J. Med. Chem. 27:1984;861.
61. Khokhar A.R., Xu Q., Al-Baker S., Bear J.L. Inorg. Chim. Acta. 194:1992;243.
62. Bruck M.A., Bau R., Noji M., Inagaki K., Kidani Y. Inorg. Chim. Acta. 92:1984;279.
63. Neidle S., Ismail I.M., Sadler P.J. J. Inorg. Biochem. 13:1980;205.
64. Hoeschele J.D., Showalter H.D.H., Kraker A.J., Elliott W.L., Robert B.J., Kampf J.W. J. Med. Chem. 37:1994;2630.
65. Rochon F.D., Melanson R., Macquet J.P., Belanger-Gariepy F., Beauchamp A.L. Inorg. Chim. Acta. 108:1985;17.
66. Yoshida M., Khokhar A.R., Siddik Z.H. Cancer Res. 54:1998;4691.